Latest On Genertec Universal Medical Group Company Limited (UMTAF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-06-12 06:06 EST | Dividend | A dividend of $0.34 has been announced on Mar 29, 2023. It will be paid Jun 27, 2023 with an ex-dividend date of Jun 12, 2023. | Neutral |  |
| 2022-06-10 06:06 EST | Dividend | A dividend of $0.36 has been announced on Mar 29, 2022. It will be paid Jun 27, 2022 with an ex-dividend date of Jun 10, 2022. | Neutral | |
| 2021-06-14 06:20 EST | Dividend | A dividend of $0.31 has been announced on Mar 31, 2021. It will be paid Jun 28, 2021 with an ex-dividend date of Jun 14, 2021. | Neutral | |
| 2020-12-04 18:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 19:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 20:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-29 10:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 11:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 03:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 23:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 06:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 06:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 06:13 EST | Dividend | A dividend of $0.29 has been announced on Mar 24, 2020. It will be paid Jun 29, 2020 with an ex-dividend date of Jun 12, 2020. | Neutral | |
| 2020-06-05 14:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 18:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 06:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 06:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 03:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 07:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 19:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 15:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 10:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-16 02:52 EST | Financials | Company financials have been released. | Neutral | |
About Genertec Universal Medical Group Company Limited (UMTAF):
Genertec Universal Medical Group Company Limited provides financing and advisory services in the People's Republic of China. The company operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; management of hospital and healthcare; and import and export trading, and trading of medical-related goods. It is also involved in the provision of medical technology; hospital digitalization and construction; property management; and medical consulting services. In addition, the company sells medical-related goods. It serves hospitals, other healthcare institutions, and educational and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.
General
- Name Genertec Universal Medical Group Company Limited
- Symbol UMTAF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 12,783
- Fiscal Year EndDecember
- Web URLhttp://www.universalmsm.com
View More
Valuation
- Trailing PE 6.9
View More
Financials
- Most Recent Quarter 2020-06-30
- Profit Margin 21%
- Return on Assets 3%
- Return on Equity 13%
- Earnings Per Share $0.12
- Revenue Per Share $0
- Gross Profit 3.18 billion
- Quarterly Earnings Growth 25.5%
View More
Highlights
- Market Capitalization 1.37 billion
- Book Value Per Share $0.69
View More
Share Statistics
- Shares Outstanding 1.72 billion
- Shares Float 1.09 billion
- % Held by Insiders 4011%
- % Held by Institutions 10.6%
View More
Technicals
- Beta 0.54
- 52 Week High $0.86
- 52 Week Low $0.51
- 50 Day Moving Average 0.79
- 200 Day Moving Average 0.72
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Per Share $0.03
- Dividend Yield 0%
View More
Genertec Universal Medical Group Company Limited (UMTAF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Genertec Universal Medical Group Company Limited (UMTAF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-06-30 | $N/A | $0.03 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $1.81 billion | $0.03 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $1.81 billion | $0.03 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $1.6 billion | $0.03 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $1.6 billion | $0.03 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $1.1 billion | $0.04 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $1.1 billion | $0.03 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $1.05 billion | $0.03 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $1.05 billion | $0.03 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $882.66 million | $0.03 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $882.66 million | $0.03 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $826.69 million | $0.02 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $826.69 million | $0.02 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $728.82 million | $0.02 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $728.82 million | $0.02 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $0.02 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.02 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.02 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.02 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.02 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.02 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.02 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.02 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.02 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.02 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.02 | $0.00 |
Genertec Universal Medical Group Company Limited (UMTAF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | 508.92 million | 508.92 million | 597.01 million |
| Selling General Administrative | N/A | N/A | 245.48 million | 245.48 million | 177.52 million |
| Gross Profit | N/A | N/A | 765.54 million | 765.54 million | 821.98 million |
| Ebit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | 520.06 million | 520.06 million | 644.46 million |
| Income Tax Expense | 133.61 million | 133.61 million | 127.99 million | 127.99 million | 160.75 million |
| Total Revenue | N/A | N/A | 1.81 billion | 1.81 billion | 1.6 billion |
| Cost of Revenue | N/A | N/A | 1.04 billion | 1.04 billion | 775.18 million |
| Total Other Income Expense Net | N/A | N/A | -11.14 million | -11.14 million | -47.45 million |
| Net Income From Continuing Operations | N/A | N/A | 380.93 million | 380.93 million | 436.26 million |
| Net Income Applicable to Common Shares | 396.7 million | 396.7 million | 338.38 million | 338.38 million | 405.99 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | 1.25 billion | 1.25 billion | -1.42 billion |
| Change to Liabilities | -353.93 million | -353.93 million | 127.13 million | 127.13 million | -91.79 million |
| Total Cash Flow from Investing Activities | -8.63 million | -8.63 million | 1.32 billion | 1.32 billion | -1.36 billion |
| Net Borrowings | 297.03 million | 297.03 million | -1.41 billion | -1.41 billion | 3.94 billion |
| Total Cash Flow from Financial Activities | N/A | N/A | -1.88 billion | -1.88 billion | 3.39 billion |
| Change to Operating Activities | -337.49 million | -337.49 million | 340.21 million | 340.21 million | -3.19 billion |
| Change in Cash | N/A | N/A | 876 million | 876 million | -269.8 million |
| Total Cash from Operating Activities | 306.99 million | 306.99 million | 1.39 billion | 1.39 billion | -2.3 billion |
| Depreciation | N/A | N/A | 43.98 million | 43.98 million | 25.97 million |
| Other Cash Flow from Investing Activities | -4.91 million | -4.91 million | -2.4 million | -2.4 million | -1.5 million |
| Change to Inventory | N/A | N/A | -13.62 million | -13.62 million | -2.28 million |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -642.86 million | -642.86 million | -474.49 million | -474.49 million | -348.12 million |
| Change to Net Income | 522.5 million | 522.5 million | 530.25 million | 530.25 million | 521.52 million |
| Capital Expenditures | N/A | N/A | 69.81 million | 69.81 million | 34.31 million |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 44.41 billion | 44.41 billion | 45.64 billion |
| Total Stockholder Equity | N/A | N/A | 11.14 billion | 11.14 billion | 10.5 billion |
| Other Current Liabilities | N/A | N/A | 1.84 billion | 1.84 billion | 1.35 billion |
| Total Assets | N/A | N/A | 57.85 billion | 57.85 billion | 57.58 billion |
| Common Stock | 4.33 billion | 4.33 billion | 4.33 billion | 4.33 billion | 4.33 billion |
| Other Current Assets | N/A | N/A | 562.18 million | 562.18 million | 3.08 billion |
| Retained Earnings | 5.5 billion | 5.5 billion | 5.16 billion | 5.16 billion | 4.48 billion |
| Other Liabilities | 2.57 billion | 2.57 billion | 2.59 billion | 2.59 billion | 2.64 billion |
| Other Assets | 485.25 million | 485.25 million | 365.46 million | 365.46 million | 677.84 million |
| Cash | N/A | N/A | 3.39 billion | 3.39 billion | 1.63 billion |
| Total Current Liabilities | N/A | N/A | 18.76 billion | 18.76 billion | 18.32 billion |
| Other Stockholder Equity | 1.73 billion | 1.73 billion | 1.65 billion | 1.65 billion | 1.69 billion |
| Property, Plant & Equipment | 2.9 billion | 2.9 billion | 2.81 billion | 2.81 billion | 1.72 billion |
| Total Current Assets | N/A | N/A | 54.12 billion | 54.12 billion | 54.99 billion |
| Long Term Investments | N/A | N/A | 481.76 million | 481.76 million | 120.06 million |
| Net Tangible Assets | 11.48 billion | 11.48 billion | 11.07 billion | 11.07 billion | 10.43 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 21.14 billion | 21.14 billion | 23.36 billion |
| Inventory | N/A | N/A | 156.73 million | 156.73 million | 93.72 million |
| Accounts Payable | N/A | N/A | 1.29 billion | 1.29 billion | 662.97 million |
Genertec Universal Medical Group Company Limited (UMTAF) Chart:
Genertec Universal Medical Group Company Limited (UMTAF) News:
Below you will find a list of latest news for Genertec Universal Medical Group Company Limited (UMTAF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Genertec Universal Medical Group Company Limited (UMTAF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Genertec Universal Medical Group Company Limited (UMTAF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|